Story perspectives

Cigna Surges 27% Revenue Despite Stock Drop

2/1/2025

31 6

Summary

Story summary

Cigna achieved a remarkable 27% revenue growth in 2024, totaling $247 billion, despite missing fourth-quarter adjusted EPS targets, leading to an 11% stock decline.
The company struggled with stop-loss medical costs, reflected in a medical loss ratio of 87.9%.
Cigna returned $8.6 billion to shareholders and announced plans for substantial share repurchases.
Analysts express mixed sentiments, with an average price target of $387.4, down from $407.00.

1 of 1

Story summary

Cigna achieved a remarkable 27% revenue growth in 2024, totaling $247 billion, despite missing fourth-quarter adjusted EPS targets, leading to an 11% stock decline.
The company struggled with stop-loss medical costs, reflected in a medical loss ratio of 87.9%.
Cigna returned $8.6 billion to shareholders and announced plans for substantial share repurchases.
Analysts express mixed sentiments, with an average price target of $387.4, down from $407.00.